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ABSTRACT 
Glioblastoma  multiforme (GBM) is the  most aggressive  form of primary brain tumours  known collectively as 
gliomas. Gliomas are graded by their microscopic appearance. As a rule, their behaviour can be predicted from histology: 
Grade I (pilocytic astrocytomas) and Grade II (benign astrocytomas) tumours are of low grade and grow slowly over 
many years. Grade IV tumours (GBM) are the most aggressive and, unfortunately, also the most common in humans, 
growing rapidly, invading and altering brain function. These tumours arise from the supporting glial cells of the brain 
during childhood and in adulthood.  
These growths do not spread throughout the body like other forms of cancer, but cause symptoms by invading the 
brain. Untreated GBMs are rapidly lethal. Most patients with GBM die of their disease in less than a year and none have 
long term survival.  
Extracranial metastases from GBM are extremely rare, with a reported frequency of only 0.44% because of the 
absence of lymphatics in the brain and the difficulty of tumours to penetrate blood vessels. A case of glioblastoma 
multiforme with the rare features of extensive liver and bone metastases is presented in this paper. © 2008 Biomedical 
Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Gliomas are malignant brain tumours of glial cells 
growing  along  white  matter  tracts.  Glioblastoma 
multiforme (GBM) is the most aggressive form of these 
primary brain tumours, which usually arise de novo or 
may develop from lower grade gliomas after many years. 
Distinct  genetic  alterations  in  GBM  cases  have  been 
identified but as a rule there is no familial history. The 
peak age of presentation is in late adult life. Reported 
series from the USA give an incidence of approximately 
20,000 cases of GBM per year.  
GBM is usually located in the cerebral hemispheres, 
with a predilection for the white matter of the centrum 
semiovale and corpus callosum. There is relative sparing 
of the basal ganglia and grey matter. Posterior fossa and 
brain  stem  gliomas  are  seen  in  a  younger  age  group. 
Multifocal  tumours  occur  in  2-5%  [1].  Contrast-
enhanced CT scans of the brain demonstrate a variable 
tumour  pattern  from  diffuse  homogenous  enhancement 
to heterogenous and ring enhancing patterns. The tumour, 
which  rarely  calcifies,  usually  extends  beyond  the 
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margins of the enhancement. MR imaging demonstrates 
ill-defined  tumour  of  a  predominantly  low  signal  on 
T1WI and heterogenous high signal on T2WI with slight 
gadolinium  enhancement  and  usually  accompanied  by 
extensive vasogenic oedema. Areas of haemorrhage and 
central  tumour  necrosis  may  also  be  seen.  Additional 
imaging methods are PET scanning where an increase in 
glucose  utilization  rates  is  seen  and  MR  spectroscopy 
where increased choline peaks are noted [2]. 
The diagnosis of GBM requires tissue obtained by 
surgical  methods.  Surgery  may  vary  from  stereotactic 
needle biopsy of deep tumours to open surgical excision 
of  surface  tumours  using  frameless  stereotaxis.  As  the 
name implies, GBM is multilobulated in appearance on 
gross  pathology,  demonstrating  quite  extensive 
vasogenic edema. It is a deeply infiltrating tumour with 
areas of haemorrhage and necrosis. Histologically, it is 
highly  cellular,  often  bizarrely  pleomorphic, 
undifferentiated  multipolar  astrocytes  with  prominent 
vascular  endothelial  proliferation  and  no  capsule  is 
demonstrable [3].  
CASE REPORT 
A  45-year-old  woman  had  complained  of 
progressive  headache  over  a  period  of  one  year  with 
associated disturbances in speech and blurring of vision 
over the last three weeks. A contrast-enhanced MRI of 
the brain  was performed in  February 2004, showing  a 
heterogeneously  enhancing  lesion  in  the  left  temporal 
lobe with an associated cystic component (Figure 1). She 
then  underwent  a  craniotomy  with  excision  of  the  left 
temporal  lobe  tumour,  which  was  diagnosed  as  a 
glioblastoma multiforme (WHO Grade 4) based on the 
histopathological findings. She received three cycles of 
radiotherapy,  commencing  three  months  post  surgery. 
Post  operatively,  the  patient’s  condition  improved  and 
she was discharged well five days after the surgery.  
She  then  presented  9  months  post-surgery  with 
complaints  of  back  pain.  An  MRI  of  the  lumbosacral 
spine revealed features suggestive of bone metastases. A 
radionuclide  bone  scan  performed  two  weeks  later 
demonstrated  extensive  skeletal  metastases.  A 
subsequent  MRI  of  the  thoraco-lumbar  spine 
demonstrated multiple areas of metastases with evidence 
of spinal cord compression at the T7 level (Figure 2).  
The  patient  by  this  time  had  also  complained  of 
vague abdominal pains, and a CT scan of the abdomen 
and  pelvis  showed  multiple  massive  hypodense  liver 
lesions of varying sizes (Figure 3). An ultrasound-guided 
core biopsy of one of these liver lesions was performed 
and was histopathologically confirmed to be that of liver 
tissue  demonstrating  abnormal  sheets  of  small  round 
‘blue’  cells  with  high  nucleocytoplasmic  ratio  and 
pleomorphism in keeping with glioblastome multiforme 
metastases (Figure 4a).  
Based on the laboratory histopathology results and 
imaging findings, a diagnosis was made of glioblastoma 
 
Figure 1  A  coronal  contrast-enhanced  MRI  of  the  brain 
demonstrating  the  heterogeneously  enhancing  left 
temporal lobe mass (glioblastoma multiforme) with an 
associated cystic component (arrow). 
 
 
 
Figure 2  A contrast-enhanced T1 weighted sagittal MRI of the 
spine demonstrating multiple enhancing lesions in the 
vertebral bodies in keeping with bony metastases and 
cord compression at T7 level (arrow). 
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Figure 3  An axial contrast-enhanced CT scan of the liver demonstrating multiple liver metastases of varying sizes 
(the largest marked with an asterisk). 
 
 
 
 
 
 
(a)  (b) 
Figure 4  The H&E stained histopathological slide of the liver biopsy demonstrating a) abnormal sheets of small 
round ‘blue’ cells with high nucleocytoplasmic ratio and pleomorphism in keeping with glioblastoma 
multiforme metastases (slide magnification x200); b) the normal appearance of the hepatocytes obtained 
from a normal part of the liver tissue (slide magnification x500). 
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multiforme (GBM) of the brain, with extensive liver and 
bone metastases.  
DISCUSSION 
Extracranial metastasis of GBM is extremely rare, 
with a reported frequency of only 0.44%. Pasquier et al. 
found metastases occurred in regional lymph nodes (51%) 
and lungs and pleura (60%) and occasionally in the bone 
(31%) and liver (22%) [4]. Metastases from GBM are 
rare for a number of reasons: the cerebrum does not have 
a lymphatic system; the intra-cranial sinuses are enclosed 
in a dense dural membrane, which makes penetration by 
tumour cells difficult; intracerebral veins are thin walled 
and  would  probably  collapse  from  compression  before 
they could be penetrated by an expanding tumour; and 
the  immunological  response  of  the  host  organ  to 
neuroglial tumour cells may prevent their growth outside 
the  central  nervous  system  [5].  A  further  explanation 
could be the short life span of patients with GBM who do 
not survive long enough to develop metastases.  
Extra-cranial  metastases  have  been  described 
following stereotactic biopsy and few cases have been 
reported to occur in the absence of previous craniotomy 
[1]. Distant metastases generally occur after craniotomy, 
when  direct  access  via  the  dural  vessels  to  the  extra-
cerebral tissue is possible. When a tumour infiltrates the 
dura mater of the middle cranial fossa, metastases tend to 
occur in the lungs and pleura given the fact that much of 
the meningeal venous system flows back into the internal 
jugular  venous  system  [2].  Haematogenous  metastases 
may occur in the bone with the vertebrae being the most 
common  site  of  bony  involvement  [6].  Lymph  node 
metastasis  is  thought  to  occur  through  connections 
between perineural spaces and lymphatic plexuses [4].  
In the present case, the patient was initially thought 
to have another malignancy giving metastases to the liver. 
However,  histopathologic  confirmation  obtained  via  a 
liver  biopsy  revealed  highly  cellular  pleomorphic  cells 
similar to that seen in the primary cerebral glioblastoma 
multiforme. Therefore, the extensive liver lesions were 
accepted  as  extra-neural  metastases  of  GBM  and  the 
patient was treated accordingly.  
Much evidence now exists to support the notion that 
the  removal  of  a  maximum  volume  of  tumour  in  the 
brain  improves  function  and  prolongs  survival  in  the 
patients  with  GBM.  Chemotherapy  is  a  controversial 
treatment as many studies have failed to show prolonged 
median  survival  in  treated  patients,  although  the 
proportion  of  long  term  survivors  may  be  somewhat 
greater.  With  distant  metastases,  chemotherapy  is  the 
only  appropriate  treatment  but  in  these  patients  the 
prognosis is very poor.  
CONCLUSION 
A case of glioblastoma multiforme of the brain with 
the rare occurrence of extensive extra-cranial metastases 
to the liver and bone is reported.  
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